Inventor
DEBINSKI WALDEMAR
US35 patents
⚠️ This page may combine multiple inventors who share the name “DEBINSKI WALDEMAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV WAKE FOREST HEALTH SCIENCES
19 patentsUS8362207B2Jan 29, 2013
Multi-level specific targeting of cancer cells with IL-13
UNIV WAKE FOREST HEALTH SCIENCES22 citations91
US9005600B2Apr 14, 2015
Compounds useful for multi-level specific targeting of cancer cells
UNIV WAKE FOREST HEALTH SCIENCES5 citations82
US10233224B2Mar 19, 2019
Nucleic acids encoding a fusion protein useful for multi-level specific targeting of cancer cells
UNIV WAKE FOREST HEALTH SCIENCES1 citations71
US9771404B2Sep 26, 2017
Multi-level specific targeting of cancer cells
UNIV WAKE FOREST HEALTH SCIENCES2 citations71
US11207380B2Dec 28, 2021
Molecular signature of cancer
UNIV WAKE FOREST HEALTH SCIENCES2 citations70
US10752667B2Aug 25, 2020
EPHA3 and multi-valent targeting of tumors
UNIV WAKE FOREST HEALTH SCIENCES1 citations66
US11976101B2May 7, 2024
Multi-level specific targeting of cancer cells
UNIV WAKE FOREST HEALTH SCIENCES0 citations61
US11136367B2Oct 5, 2021
Multi-level specific targeting of cancer cells
UNIV WAKE FOREST HEALTH SCIENCES0 citations61
US11655299B2May 23, 2023
Antibodies against human and canine IL-13RA2
UNIV WAKE FOREST HEALTH SCIENCES0 citations60
US8343461B2Jan 1, 2013
Molecular signature of cancer
UNIV WAKE FOREST HEALTH SCIENCES2 citations60
US12419934B2Sep 23, 2025
Molecular signature of cancer
UNIV WAKE FOREST HEALTH SCIENCES0 citations59
US11697675B2Jul 11, 2023
EPHA3 and multi-valent targeting of tumors
UNIV WAKE FOREST HEALTH SCIENCES0 citations55
US10519210B2Dec 31, 2019
Multi-level specific targeting of cancer cells
UNIV WAKE FOREST HEALTH SCIENCES0 citations51
US10676529B2Jun 9, 2020
Antibodies against human and canine IL-13RA2
UNIV WAKE FOREST HEALTH SCIENCES0 citations50
US9878013B2Jan 30, 2018
IL-13 receptor binding peptides
UNIV WAKE FOREST HEALTH SCIENCES0 citations50
US9868788B2Jan 16, 2018
Antibodies against human and canine IL-13RA2
UNIV WAKE FOREST HEALTH SCIENCES0 citations50
US9974830B2May 22, 2018
Molecular signature of cancer
UNIV WAKE FOREST HEALTH SCIENCES0 citations49
US9290558B2Mar 22, 2016
Molecular signature of cancer
UNIV WAKE FOREST HEALTH SCIENCES0 citations49
US9975942B2May 22, 2018
EPHA3 And multi-valent targeting of tumors
UNIV WAKE FOREST HEALTH SCIENCES0 citations45
PENN STATE RES FOUND
8 patentsUS7338929B2Mar 4, 2008
Cancer immunotherapy
PENN STATE RES FOUND74 citations95
US6630576B2Oct 7, 2003
Amino acid substitution mutants of interleukin 13
PENN STATE RES FOUND24 citations92
US6296843B1Oct 2, 2001
Mutagenized IL 13-based chimeric molecules
PENN STATE RES FOUND36 citations92
US6884603B2Apr 26, 2005
Nucleic acids encoding IL13 mutants
PENN STATE RES FOUND19 citations90
US6576232B1Jun 10, 2003
IL13 mutants
PENN STATE RES FOUND45 citations90
US7598058B2Oct 6, 2009
Nucleic acids encoding IL13 mutants
PENN STATE RES FOUND7 citations71
US7960361B2Jun 14, 2011
Nucleic acid cancer immunotherapy
PENN STATE RES FOUND3 citations60
US6884581B2Apr 26, 2005
Method for identifying a test compound that modulates expression of a Fra-1 gene in a brain cancer cell
PENN STATE RES FOUND5 citations54